Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry
Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Behrendt, Patrick [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN - Hanief, M. ELSEVIER, 2015transfer abstract, a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:147 ; year:2017 ; pages:19-28 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.antiviral.2017.09.006 |
|---|
| Katalog-ID: |
ELV040916987 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV040916987 | ||
| 003 | DE-627 | ||
| 005 | 20230624081020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180725s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.antiviral.2017.09.006 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000276A.pica |
| 035 | |a (DE-627)ELV040916987 | ||
| 035 | |a (ELSEVIER)S0166-3542(16)30671-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 670 |q VZ |
| 082 | 0 | 4 | |a 530 |q VZ |
| 082 | 0 | 4 | |a 660 |q VZ |
| 082 | 0 | 4 | |a 000 |a 150 |q VZ |
| 084 | |a 54.74 |2 bkl | ||
| 100 | 1 | |a Behrendt, Patrick |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| 264 | 1 | |c 2017 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. | ||
| 650 | 7 | |a Entry inhibitor |2 Elsevier | |
| 650 | 7 | |a Natural compounds |2 Elsevier | |
| 650 | 7 | |a Antivirals |2 Elsevier | |
| 650 | 7 | |a Cortex moutan |2 Elsevier | |
| 650 | 7 | |a Bioavailability |2 Elsevier | |
| 650 | 7 | |a Hepatitis C virus |2 Elsevier | |
| 650 | 7 | |a Penta-O-Galloyl-Glucose |2 Elsevier | |
| 700 | 1 | |a Perin, Paula |4 oth | |
| 700 | 1 | |a Menzel, Nicolas |4 oth | |
| 700 | 1 | |a Banda, Dominic |4 oth | |
| 700 | 1 | |a Pfaender, Stephanie |4 oth | |
| 700 | 1 | |a Alves, Marco P. |4 oth | |
| 700 | 1 | |a Thiel, Volker |4 oth | |
| 700 | 1 | |a Meuleman, Philip |4 oth | |
| 700 | 1 | |a Colpitts, Che C. |4 oth | |
| 700 | 1 | |a Schang, Luis M. |4 oth | |
| 700 | 1 | |a Vondran, Florian W.R. |4 oth | |
| 700 | 1 | |a Anggakusuma |4 oth | |
| 700 | 1 | |a Manns, Michael P. |4 oth | |
| 700 | 1 | |a Steinmann, Eike |4 oth | |
| 700 | 1 | |a Pietschmann, Thomas |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Hanief, M. ELSEVIER |t Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |d 2015transfer abstract |d a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research |g Amsterdam [u.a.] |w (DE-627)ELV012905879 |
| 773 | 1 | 8 | |g volume:147 |g year:2017 |g pages:19-28 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.antiviral.2017.09.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 54.74 |j Maschinelles Sehen |q VZ |
| 951 | |a AR | ||
| 952 | |d 147 |j 2017 |h 19-28 |g 10 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
p b pb |
|---|---|
| matchkey_str |
behrendtpatrickperinpaulamenzelnicolasba:2017----:etglollcsaihyiaalbeoyhnlcopudrsnicremuaefce |
| hierarchy_sort_str |
2017 |
| bklnumber |
54.74 |
| publishDate |
2017 |
| allfields |
10.1016/j.antiviral.2017.09.006 doi GBV00000000000276A.pica (DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Behrendt, Patrick verfasserin aut Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier Perin, Paula oth Menzel, Nicolas oth Banda, Dominic oth Pfaender, Stephanie oth Alves, Marco P. oth Thiel, Volker oth Meuleman, Philip oth Colpitts, Che C. oth Schang, Luis M. oth Vondran, Florian W.R. oth Anggakusuma oth Manns, Michael P. oth Steinmann, Eike oth Pietschmann, Thomas oth Enthalten in Elsevier Science Hanief, M. ELSEVIER Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN 2015transfer abstract a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research Amsterdam [u.a.] (DE-627)ELV012905879 volume:147 year:2017 pages:19-28 extent:10 https://doi.org/10.1016/j.antiviral.2017.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 54.74 Maschinelles Sehen VZ AR 147 2017 19-28 10 045F 610 |
| spelling |
10.1016/j.antiviral.2017.09.006 doi GBV00000000000276A.pica (DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Behrendt, Patrick verfasserin aut Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier Perin, Paula oth Menzel, Nicolas oth Banda, Dominic oth Pfaender, Stephanie oth Alves, Marco P. oth Thiel, Volker oth Meuleman, Philip oth Colpitts, Che C. oth Schang, Luis M. oth Vondran, Florian W.R. oth Anggakusuma oth Manns, Michael P. oth Steinmann, Eike oth Pietschmann, Thomas oth Enthalten in Elsevier Science Hanief, M. ELSEVIER Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN 2015transfer abstract a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research Amsterdam [u.a.] (DE-627)ELV012905879 volume:147 year:2017 pages:19-28 extent:10 https://doi.org/10.1016/j.antiviral.2017.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 54.74 Maschinelles Sehen VZ AR 147 2017 19-28 10 045F 610 |
| allfields_unstemmed |
10.1016/j.antiviral.2017.09.006 doi GBV00000000000276A.pica (DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Behrendt, Patrick verfasserin aut Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier Perin, Paula oth Menzel, Nicolas oth Banda, Dominic oth Pfaender, Stephanie oth Alves, Marco P. oth Thiel, Volker oth Meuleman, Philip oth Colpitts, Che C. oth Schang, Luis M. oth Vondran, Florian W.R. oth Anggakusuma oth Manns, Michael P. oth Steinmann, Eike oth Pietschmann, Thomas oth Enthalten in Elsevier Science Hanief, M. ELSEVIER Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN 2015transfer abstract a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research Amsterdam [u.a.] (DE-627)ELV012905879 volume:147 year:2017 pages:19-28 extent:10 https://doi.org/10.1016/j.antiviral.2017.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 54.74 Maschinelles Sehen VZ AR 147 2017 19-28 10 045F 610 |
| allfieldsGer |
10.1016/j.antiviral.2017.09.006 doi GBV00000000000276A.pica (DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Behrendt, Patrick verfasserin aut Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier Perin, Paula oth Menzel, Nicolas oth Banda, Dominic oth Pfaender, Stephanie oth Alves, Marco P. oth Thiel, Volker oth Meuleman, Philip oth Colpitts, Che C. oth Schang, Luis M. oth Vondran, Florian W.R. oth Anggakusuma oth Manns, Michael P. oth Steinmann, Eike oth Pietschmann, Thomas oth Enthalten in Elsevier Science Hanief, M. ELSEVIER Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN 2015transfer abstract a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research Amsterdam [u.a.] (DE-627)ELV012905879 volume:147 year:2017 pages:19-28 extent:10 https://doi.org/10.1016/j.antiviral.2017.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 54.74 Maschinelles Sehen VZ AR 147 2017 19-28 10 045F 610 |
| allfieldsSound |
10.1016/j.antiviral.2017.09.006 doi GBV00000000000276A.pica (DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Behrendt, Patrick verfasserin aut Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier Perin, Paula oth Menzel, Nicolas oth Banda, Dominic oth Pfaender, Stephanie oth Alves, Marco P. oth Thiel, Volker oth Meuleman, Philip oth Colpitts, Che C. oth Schang, Luis M. oth Vondran, Florian W.R. oth Anggakusuma oth Manns, Michael P. oth Steinmann, Eike oth Pietschmann, Thomas oth Enthalten in Elsevier Science Hanief, M. ELSEVIER Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN 2015transfer abstract a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research Amsterdam [u.a.] (DE-627)ELV012905879 volume:147 year:2017 pages:19-28 extent:10 https://doi.org/10.1016/j.antiviral.2017.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 54.74 Maschinelles Sehen VZ AR 147 2017 19-28 10 045F 610 |
| language |
English |
| source |
Enthalten in Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN Amsterdam [u.a.] volume:147 year:2017 pages:19-28 extent:10 |
| sourceStr |
Enthalten in Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN Amsterdam [u.a.] volume:147 year:2017 pages:19-28 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Maschinelles Sehen |
| institution |
findex.gbv.de |
| topic_facet |
Entry inhibitor Natural compounds Antivirals Cortex moutan Bioavailability Hepatitis C virus Penta-O-Galloyl-Glucose |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |
| authorswithroles_txt_mv |
Behrendt, Patrick @@aut@@ Perin, Paula @@oth@@ Menzel, Nicolas @@oth@@ Banda, Dominic @@oth@@ Pfaender, Stephanie @@oth@@ Alves, Marco P. @@oth@@ Thiel, Volker @@oth@@ Meuleman, Philip @@oth@@ Colpitts, Che C. @@oth@@ Schang, Luis M. @@oth@@ Vondran, Florian W.R. @@oth@@ Anggakusuma @@oth@@ Manns, Michael P. @@oth@@ Steinmann, Eike @@oth@@ Pietschmann, Thomas @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012905879 |
| dewey-sort |
3610 |
| id |
ELV040916987 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040916987</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624081020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.antiviral.2017.09.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000276A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040916987</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0166-3542(16)30671-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">000</subfield><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.74</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Behrendt, Patrick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Entry inhibitor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Natural compounds</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antivirals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cortex moutan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioavailability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis C virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Penta-O-Galloyl-Glucose</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perin, Paula</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menzel, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Banda, Dominic</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pfaender, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alves, Marco P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thiel, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meuleman, Philip</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Colpitts, Che C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schang, Luis M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vondran, Florian W.R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anggakusuma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manns, Michael P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Eike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pietschmann, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Hanief, M. ELSEVIER</subfield><subfield code="t">Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN</subfield><subfield code="d">2015transfer abstract</subfield><subfield code="d">a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012905879</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:147</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:19-28</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.antiviral.2017.09.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.74</subfield><subfield code="j">Maschinelles Sehen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">147</subfield><subfield code="j">2017</subfield><subfield code="h">19-28</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Behrendt, Patrick |
| spellingShingle |
Behrendt, Patrick ddc 610 ddc 670 ddc 530 ddc 660 ddc 000 bkl 54.74 Elsevier Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| authorStr |
Behrendt, Patrick |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012905879 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 670 - Manufacturing 530 - Physics 660 - Chemical engineering 000 - Computer science, information & general works 150 - Psychology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose Elsevier |
| topic |
ddc 610 ddc 670 ddc 530 ddc 660 ddc 000 bkl 54.74 Elsevier Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose |
| topic_unstemmed |
ddc 610 ddc 670 ddc 530 ddc 660 ddc 000 bkl 54.74 Elsevier Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose |
| topic_browse |
ddc 610 ddc 670 ddc 530 ddc 660 ddc 000 bkl 54.74 Elsevier Entry inhibitor Elsevier Natural compounds Elsevier Antivirals Elsevier Cortex moutan Elsevier Bioavailability Elsevier Hepatitis C virus Elsevier Penta-O-Galloyl-Glucose |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
p p pp n m nm d b db s p sp m p a mp mpa v t vt p m pm c c c cc ccc l m s lm lms f w v fw fwv a m p m mp mpm e s es t p tp |
| hierarchy_parent_title |
Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |
| hierarchy_parent_id |
ELV012905879 |
| dewey-tens |
610 - Medicine & health 670 - Manufacturing 530 - Physics 660 - Chemical engineering 000 - Computer science, knowledge & systems 150 - Psychology |
| hierarchy_top_title |
Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012905879 |
| title |
Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| ctrlnum |
(DE-627)ELV040916987 (ELSEVIER)S0166-3542(16)30671-4 |
| title_full |
Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| author_sort |
Behrendt, Patrick |
| journal |
Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |
| journalStr |
Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science 000 - Computer science, information & general works 100 - Philosophy & psychology |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
19 |
| author_browse |
Behrendt, Patrick |
| container_volume |
147 |
| physical |
10 |
| class |
610 610 DE-600 670 VZ 530 VZ 660 VZ 000 150 VZ 54.74 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Behrendt, Patrick |
| doi_str_mv |
10.1016/j.antiviral.2017.09.006 |
| dewey-full |
610 670 530 660 000 150 |
| title_sort |
pentagalloylglucose, a highly bioavailable polyphenolic compound present in cortex moutan, efficiently blocks hepatitis c virus entry |
| title_auth |
Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| abstract |
Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. |
| abstractGer |
Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. |
| abstract_unstemmed |
Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry |
| url |
https://doi.org/10.1016/j.antiviral.2017.09.006 |
| remote_bool |
true |
| author2 |
Perin, Paula Menzel, Nicolas Banda, Dominic Pfaender, Stephanie Alves, Marco P. Thiel, Volker Meuleman, Philip Colpitts, Che C. Schang, Luis M. Vondran, Florian W.R. Anggakusuma Manns, Michael P. Steinmann, Eike Pietschmann, Thomas |
| author2Str |
Perin, Paula Menzel, Nicolas Banda, Dominic Pfaender, Stephanie Alves, Marco P. Thiel, Volker Meuleman, Philip Colpitts, Che C. Schang, Luis M. Vondran, Florian W.R. Anggakusuma Manns, Michael P. Steinmann, Eike Pietschmann, Thomas |
| ppnlink |
ELV012905879 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.antiviral.2017.09.006 |
| up_date |
2024-07-06T18:43:57.858Z |
| _version_ |
1803856314745487360 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040916987</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624081020.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.antiviral.2017.09.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000276A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040916987</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0166-3542(16)30671-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">000</subfield><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.74</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Behrendt, Patrick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Entry inhibitor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Natural compounds</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antivirals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cortex moutan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioavailability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis C virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Penta-O-Galloyl-Glucose</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perin, Paula</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menzel, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Banda, Dominic</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pfaender, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alves, Marco P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thiel, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meuleman, Philip</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Colpitts, Che C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schang, Luis M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vondran, Florian W.R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anggakusuma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manns, Michael P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Eike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pietschmann, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Hanief, M. ELSEVIER</subfield><subfield code="t">Modeling and prediction of surface roughness for running-in wear using Gauss-Newton algorithm and ANN</subfield><subfield code="d">2015transfer abstract</subfield><subfield code="d">a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines : an official publication of the International Society for Antiviral Research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012905879</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:147</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:19-28</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.antiviral.2017.09.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.74</subfield><subfield code="j">Maschinelles Sehen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">147</subfield><subfield code="j">2017</subfield><subfield code="h">19-28</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4010954 |